K(ATP) channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats

European Journal of Pharmacology

Volumn 324, Issue 1, 1997, Pages 77-83

  Baczkó, István ^a   Leprán, István ^a   Papp, Julius Gy ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Anesthetized rat; Cromakalim; Glibenclamide; Pinacidil; Reperfusioa arrhythmia

Indexed keywords

CROMAKALIM; GLIBENCLAMIDE; PINACIDIL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; ANTIARRHYTHMIC AGENT; BENZOPYRAN DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; GUANIDINE DERIVATIVE; POTASSIUM CHANNEL; PYRROLE DERIVATIVE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL RATE; ACTION POTENTIAL; ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART RATE; METABOLISM; MORTALITY; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; BENZOPYRANS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CORONARY DISEASE; CROMAKALIM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; GLYBURIDE; GUANIDINES; HEART RATE; MALE; MYOCARDIAL REPERFUSION INJURY; PINACIDIL; POTASSIUM CHANNELS; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; VASODILATOR AGENTS; VENTRICULAR FIBRILLATION;

EID: 0031564530     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00064-2     Document Type: Article

References (50)

1. Ballagi-Pordany, G., Koszeghy, A., Koltai, M.Z., Aranyi, Z., Pogatsa, G., 1990. Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds. Diabetes Res. Clin. Pract. 8, 109-114.
2. Black, S.C., Lucchesi, B.R., 1994. Potassium channel openers are likely to be proarrhythmic in the diseased human heart. Cardiovasc. Res. 28, 923.
3. Brooks, W.W., Conrad, C.H., Morgan, J.P., 1995. Reperfusion induced arrhythmias following ischaemia in intact rat heart: role of intracellular calcium. Cardiovasc. Res. 29, 536-542.
4. Cacciapuoti, F., Spiezia, R., Bianchi, U., Lama, D., D'Avino, M., Varricchio, M., 1991. Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus. Am. J. Cardiol. 67, 843-847.
5. Chi, L., Uprichard, A.C.G., Lucchesi, B.R., 1990. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J. Cardiovasc. Pharmacol. 15, 452-464.
6. + channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69, 571-581.
7. ATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia. Cardiovasc. Res. 28, 881-887.
8. Delacoussaye, J.E., Eldedjam, J.J., Bruelle, P., Peray, P.A., Bassoul, B.P., Gagnol, J.P., Sassine, A., 1993. Electrophysiologic and arrhythmogenic effects of the potassium channel agonist BRL 38227 in anesthetized dogs. J. Cardiovasc. Pharmacol. 22, 722-730.
9. Di Diego, J.M., Antzelevitch, C., 1993. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation 88, 1177-1189.
10. + channel openers and 'natural' cardioprotection. Trends Pharmacol. Sci. 13, 269-272.
11. Fagbemi, O.S., Chi, L., Lucchesi, B.R., 1993. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents. J. Cardiovasc. Pharmacol. 21, 709-719.
12. Fish, F.A., Prakash, C., Roden, D.M., 1990. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation 82, 1362-1369.
13. Friedel, H.A., Brogden, R.N., 1990. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and the therapeutic potential in the treatment of hypertension. Drugs 39, 929-967.
14. Gasser, R.N.A., Vaughan-Jones, R.D., 1990. Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle. J. Physiol. (London) 431, 713-741.
15. Gilbert, J.P., Saracci, R., Meier, P., Zelen, M., Rumke, C.L., White, C., 1975. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents. J. Am. Med. Assoc. 231, 583-608.
16. Grover, G.J., 1994. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J. Cardiovasc. Pharmacol. 24 (Suppl. 4), S18-S27.
17. Grover, G.J., McCullough, J.R., D'Alonzo, A.J., Sargent, C.A., Atwal, K.S., 1995. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. J. Cardiovasc. Pharmacol. 25, 40-50.
18. Haverkamp, W., Borggrefe, M., Breithardt, G., 1995. Electrophysiologic effects of potassium channel openers. Cardiovasc. Drug Ther. 9, 195-202.
19. Janse, M., Wit, A.L., 1989. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69, 1049-1169.
20. Kaiser, J., Englert, H.C., Kurjat, M., Linz, W., 1994. Profibrillatory effect of pinacidil and its antagonism by low concentrations of glibenclamide in isolated guinea pig hearts. Naunyn-Schmiedeberg's Arch. Pharmacol. 349 (Suppl.), R46.
21. Kane, K.A., Parratt, J.R., Williams, F.M., 1984. An investigation into the characteristics of reperfusion-induced arrhythmias in the anesthetized rat and their susceptibility to antiarrhythmic agents. Br. J. Pharmacol. 82, 349-357.
22. + loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulphonylurea. Circ. Res. 66, 478-485.
23. Kaski, J.C., 1995. Management of vasospastic angina: role of nicorandil. Cardiovasc. Drug Ther. 9, 221-227.
24. Knight, C., Purcell, H., Fox, K., 1995. Potassium channel openers: clinical applications in ischemic heart disease - overview of clinical efficacy of nicorandil. Cardiovasc. Drug Ther. 9, 229-236.
25. Lepran, I., Szekeres, L., 1992. Effect of dietary sunflower seed oil on the severity of reperfusion-induced arrhythmias in anesthetized rats. J. Cardiovasc. Pharmacol. 19, 40-44.
26. Lepran, I., Koltai, M., Siegmund, W., Szekeres, L., 1983. Coronary artery ligation, early arrhythmias and determination of the ischaemic area in conscious rats. J. Pharmacol. Methods 9, 219-230.
27. Lepran, I., Baczko, I., Varro, A., Papp, J.Gy., 1996. ATP-sensitive potassium channel modulators: both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats. J. Pharmacol. Exp. Ther. 277, 1215-1220.
28. Licata, G., Ganguzza, A., Galletti, F., Poeta, F., Boschetti, E., Pirrelli, A., Vulpis, V., Ravera, B., Guglielmi, M., Stornello, M., Tamburino, G., Malatino, L., Iovino, G., Rodegher, P., 1995. Multicenter, double-blind clinical trial with different doses of pinacidil in patients with mild-to-moderate essential hypertension. Curr. Ther. Res. 56, 445-456.
29. +-channel in rat models of reperfusion-induced arrhythmias. Naunyn-Schmiedeberg's Arch. Pharmacol. 349 (Suppl.), R47.
30. Lomuscio, A., Vergani, D., Marano, L., Castagnone, M., Fiorentini, C., 1994. Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction. Coron. Artery Dis. 5, 767-771.
31. Manning, A.S., Hearse, D.J., 1984. Reperfusion-induced arrhythmias: mechanisms and prevention. J. Mol. Cell. Cardiol. 16, 497-518.
32. Maxwell, M.P., Hearse, D.J., Yellon, D.M., 1987. Species variation on the coronary collateral circulation during myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc. Res. 21, 737-746.
33. Meinert, C.L., Knatterud, G.L., Prout, T.E., Klimt, C.R., 1970. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19 (Suppl. 2), 789-830.
34. Nattrass, M., 1986. Treatment of type II diabetes. Br. Med. J. Clin. Res. Ed. 292, 1033-1034.
35. Nienaber, C., Gottwick, M., Winkler, B., Schaper, W., 1983. The relationship between perfusion deficit, infarct size and time after experimental coronary occlusion. Basic Res. Cardiol. 78, 210-226.
36. + channels in cardiac muscle, Nature 305, 147-149.
37. Pogatsa, G., Koltai, M.Z., Balkanyi, I., Devai, I., Kiss, V., Koszeghy, A., 1988. The effect of various hypoglycaemic sulphonylureas on the cardiotoxicity of glycosides and arrhythmogenic activity due to myocardial ischaemia. Acta Physiol. Hung. 71, 243-250.
38. Rees, S.A., Curtis, M.J., 1995. Pharmacological analysis in rat of the role of the ATP-sensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia. J. Cardiovasc. Pharmacol. 26, 280-288.
39. Smallwood, J.K., Schelm, J.A., Bemis, K.G., Simpson, P.J., 1993. Effect of activation of ATP-dependent potassium channels with (-)-pinacidil and (-)-3-pyridyl pinacidil on infarct size in a canine model of ischemia-reperfusion injury. J. Cardiovasc. Pharmacol. 22, 731-743.
40. Tosaki, A., Hellegourach, A., 1994. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischaemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts. J. Am. Coll. Cardiol. 23, 487-496.
41. Tosaki, A., Szerdahelyi, P., Engelman, R.M., Das, D.K., 1993. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J. Pharmacol. Exp. Ther. 267, 1355-1362.
42. Tweedie, D., Henderson, C., Kane, K., 1993. Glibenclamide, but not class III drugs, prevents ischaemic shortening of the refractory period in guinea-pig hearts. Eur. J. Pharmacol. 240, 251-257.
43. Walker, M.J.A., Curtis, M.J., Hearse, D.J., Campbell, R.W.F., Janse, M.J., Yellon, D.M., Cobbe, S.M., Coker, S.J., Harness, J.B., Harron, D.W.G. et al., 1988. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovasc. Res. 22, 447-455.
44. Wallenstein, S., Zucher, C.L., Fleiss, J.L., 1980. Some statistical methods useful in circulation research. Circ. Res. 47, 1-9.
45. +-channel opening and arrhythmogenesis. J. Cardiovasc. Pharmacol. 24 (Suppl. 4), S35-S40.
46. Wilde, A.A.M., Janse, M.J., 1994. Electrophysiological effects of ATP-sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc. Res. 28, 16-24.
47. Wolleben, C.D., Sanquinetti, M.C., Siegl, P.K.S., 1989. Influence of ATP-sensitive potassium modulators on ischemia-induced fibrillation in isolated rat hearts. J. Mol. Cell. Cardiol. 21, 783-788.
48. Yao, Z., Gross, G.J., 1994. The ATP-dependent potassium channel: an endogenous cardioprotective mechanism. J. Cardiovasc. Pharmacol. 24 (Suppl. 4), S28-S34.
49. ATP channels: an endogenous protective mechanism during repetitive ischaemia. Am. J. Physiol. 264, H495-H504.
50. Zhang, H.L., Li, Y.S., Fu, S.X., Yang, X.P., 1991. Effects of glibenclamide and tolbutamide on ischaemia-induced and ouabain-induced arrhythmias and membrane potentials of ventricular myocardium from rat and guinea pig. Acta Pharmacol. Sin. 12, 398-402.